MedDataX Logo

Aquablation in Benign Prostatic Hyperplasia in Canada

NCT ID: NCT05169892

Last Updated: 2021-12-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

25 participants

Study Classification

OBSERVATIONAL

Study Start Date

2019-10-09

Study Completion Date

2026-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To document the clinical outcome of Aquablation therapy for BPH patient in Canadian cohort.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Patients will be followed up for 3 years as standard of care.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Urologic Diseases

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

benigh prostate hypertrophy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Aquablation

Aquablation

Intervention Type PROCEDURE

Aquablation

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Aquablation

Aquablation

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Primary diagnosis of Benign Prostate Hypertrophy (BPH)
* Male subjects of ≥ 18 years of age
* Candidate for Aquablation therapy as per clinical decision of Investigator
* Willing and able to accurately complete questionnaires
* Willing and able to provide signed and dated informed consent

Exclusion Criteria

* Characteristics indicating a poor compliance with study protocol requirements.
* Disease or other health condition that is not suitable for this study.
* Unable or unwilling to provide signed informed consent.
Minimum Eligible Age

18 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Can-Am HIFU Inc.

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Dean Elterman

Urologist

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Dean Elterman

Toronto, Ontario, Canada

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Canada

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Dean Elterman

Role: CONTACT

Phone: 4166035800

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Dean Elterman

Role: primary

Iris Chan

Role: backup

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Aquablation in BPH

Identifier Type: -

Identifier Source: org_study_id